It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HROW’s FA Score shows that 2 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HROW’s TA Score shows that 4 TA indicator(s) are bullish while RMTI’s TA Score has 5 bullish TA indicator(s).
HROW (@Pharmaceuticals: Other) experienced а -14.13% price change this week, while RMTI (@Pharmaceuticals: Other) price change was -40.57% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +56.20%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -6.95%.
HROW is expected to report earnings on Mar 13, 2025.
RMTI is expected to report earnings on Mar 13, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
HROW | RMTI | HROW / RMTI | |
Capitalization | 468M | 49.9M | 938% |
EBITDA | 9.95M | -4.69M | -212% |
Gain YTD | 282.679 | 31.746 | 890% |
P/E Ratio | 39.53 | N/A | - |
Revenue | 130M | 83.6M | 156% |
Total Cash | 82.8M | 10.9M | 760% |
Total Debt | 191M | 13.4M | 1,425% |
HROW | RMTI | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 68 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 15 | 100 | |
SMR RATING 1..100 | 97 | 97 | |
PRICE GROWTH RATING 1..100 | 34 | 52 | |
P/E GROWTH RATING 1..100 | 16 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RMTI's Valuation (51) in the Medical Specialties industry is somewhat better than the same rating for HROW (85) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew somewhat faster than HROW’s over the last 12 months.
HROW's Profit vs Risk Rating (15) in the Pharmaceuticals Other industry is significantly better than the same rating for RMTI (100) in the Medical Specialties industry. This means that HROW’s stock grew significantly faster than RMTI’s over the last 12 months.
HROW's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as RMTI (97) in the Medical Specialties industry. This means that HROW’s stock grew similarly to RMTI’s over the last 12 months.
HROW's Price Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as RMTI (52) in the Medical Specialties industry. This means that HROW’s stock grew similarly to RMTI’s over the last 12 months.
HROW's P/E Growth Rating (16) in the Pharmaceuticals Other industry is significantly better than the same rating for RMTI (100) in the Medical Specialties industry. This means that HROW’s stock grew significantly faster than RMTI’s over the last 12 months.
HROW | RMTI | |
---|---|---|
RSI ODDS (%) | 1 day ago86% | 1 day ago89% |
Stochastic ODDS (%) | 1 day ago82% | 1 day ago83% |
Momentum ODDS (%) | 1 day ago82% | 1 day ago88% |
MACD ODDS (%) | 1 day ago87% | 1 day ago89% |
TrendWeek ODDS (%) | 1 day ago80% | 1 day ago89% |
TrendMonth ODDS (%) | 1 day ago78% | 1 day ago88% |
Advances ODDS (%) | 8 days ago0% | 5 days ago85% |
Declines ODDS (%) | 4 days ago78% | 1 day ago88% |
BollingerBands ODDS (%) | N/A | 1 day ago87% |
Aroon ODDS (%) | 1 day ago78% | 1 day ago88% |
A.I.dvisor tells us that HROW and RMTI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HROW and RMTI's prices will move in lockstep.
Ticker / NAME | Correlation To HROW | 1D Price Change % | ||
---|---|---|---|---|
HROW | 100% | -17.26% | ||
RMTI - HROW | 22% Poorly correlated | -5.32% | ||
AMPH - HROW | 21% Poorly correlated | -0.92% | ||
AMRX - HROW | 20% Poorly correlated | -0.33% | ||
CRON - HROW | 17% Poorly correlated | -4.61% | ||
SIGA - HROW | 14% Poorly correlated | -4.69% | ||
More |
A.I.dvisor tells us that RMTI and ESPR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RMTI and ESPR's prices will move in lockstep.
Ticker / NAME | Correlation To RMTI | 1D Price Change % | ||
---|---|---|---|---|
RMTI | 100% | -5.32% | ||
ESPR - RMTI | 27% Poorly correlated | -5.83% | ||
AMRX - RMTI | 26% Poorly correlated | -0.33% | ||
PROC - RMTI | 24% Poorly correlated | -6.47% | ||
AMPH - RMTI | 24% Poorly correlated | -0.92% | ||
HROW - RMTI | 24% Poorly correlated | -17.26% | ||
More |